Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Microfluidic Device Design for Point-of-Care Devices
Case ID:
M25-116L
Web Published:
9/29/2025
Implementing liquid-based assays, such as PCR and LAMP, is difficult in POC microfluidic devices, due to bubble formation. To mitigate this, auxiliary metering systems or actuators are required to regulate consistent flow rates. This can make the microfluidic device more complicated to operate, increases cost, and limits rapid prototyping, ultimately hindering their usefulness in resource-limited environments. Further, the formation of bubbles prevents accurate quantitative measurements, such as for fluorescence-based assays.
Researchers at Arizona State University have developed a novel microfluidic configuration designed for nucleic acid amplification, that integrates a unique same-depth inlet outlet (SDIO) reaction chamber to minimize bubble formation. Utilizing rapid fabrication methods including xurography, laser cutting, and lamination, it allows for low-cost prototyping. Material compatibility with loop-mediated isothermal amplification (LAMP) assays is assessed, and effective decontamination techniques using ethanol rinses and ultraviolet-C light are implemented to reduce nuclease contamination. Validation using SARS-CoV-2 RT-LAMP assays demonstrate its suitability for early-stage diagnostics development in resource-limited environments.
This microfluidic device design can be used with liquid-based assays with minimal bubble formation, making it suitable in low-resource POC applications for both qualitative and quantitative measurements.
Potential Applications
Point-of-care infectious disease diagnostics
Rapid prototype development for microfluidic devices
Resource-limited and remote healthcare testing
Early-stage development of nucleic acid amplification assays
Environmental and food safety monitoring using nucleic acid detection
Benefits and Advantages
Significantly reduces bubble formation with novel SDIO chamber design
Rapid and inexpensive prototyping via xurography, laser cutting, and lamination
Enhanced assay reliability through careful material and adhesive selection
Effective decontamination methods to reduce nuclease contamination
Validated for sensitive nucleic acid amplification including SARS-CoV-2 detection
Suitable for resource-limited and point-of-care diagnostic settings
For more information about this opportunity, please see
Nguyen et al – Sensors and Actuators Reports - 2025
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Microfluidic_Device_Design_f or_Point-of-Care_Devices
Keywords:
Bookmark this page
Download as PDF
For Information, Contact:
Jovan Heusser
Director of Licensing and Business Development
Skysong Innovations
jovan.heusser@skysonginnovations.com